Supernus Pharmaceuticals Inc
SUPN35.610USD
+0.105+0.30%
交易中 （美東）報價延遲15分鐘
1.99B總市值
32.20本益比TTM
關於 Supernus Pharmaceuticals Inc 公司
Supernus Pharmaceuticals, Inc. 是一家生物製藥公司。該公司專注於開發和商業化用於治療中樞神經系統 (CNS) 疾病的產品。其多樣化的神經科學產品組合包括已獲批的治療癲癇、偏頭痛、注意力缺陷多動障礙 (ADHD)、帕金森病 (PD) 中的運動障礙、頸部肌張力障礙、慢性流涎症、接受左旋多巴治療的 PD 患者的運動障礙以及成人患者藥物引起的錐體外系反應的藥物。該公司還在開發一系列新型 CNS 產品候選藥物，包括用於治療 PD 中的運動障礙、癲癇、抑鬱症和其他 CNS 疾病的新潛在療法。其商業產品包括 Qelbree（維洛沙嗪）、GOCOVRI（金剛烷胺）、Oxtellar XR（奧卡西平）、Trokendi XR（託吡酯）、APOKYN（鹽酸阿撲嗎啡注射液）等。 Qelbree（維洛沙嗪）是一種新型非興奮劑產品，用於治療 ADHD。
公司簡介
公司代碼SUPN
公司名稱Supernus Pharmaceuticals Inc
上市日期Dec 28, 2010
CEOMr. Jack A. Khattar
員工數量674
證券類型Ordinary Share
年結日Dec 28
公司地址9715 Key West Avenue
城市ROCKVILLE
上市交易所NASDAQ Global Market Consolidated
國家United States of America
郵編20850
電話13018382500
網址https://www.supernus.com
公司代碼SUPN
上市日期Dec 28, 2010
CEOMr. Jack A. Khattar
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Jack A. Khattar
Mr. Jack A. Khattar
President, Chief Executive Officer, Secretary, Director
President, Chief Executive Officer, Secretary, Director
2.01M
--
Mr. Frederick M. Hudson, CPA
Mr. Frederick M. Hudson, CPA
Independent Director
Independent Director
53.76K
--
Dr. Carrolee Barlow, M.D., Ph.D.
Dr. Carrolee Barlow, M.D., Ph.D.
Independent Director
Independent Director
22.57K
--
Dr. Georges Gemayel, Ph.D.
Dr. Georges Gemayel, Ph.D.
Independent Director
Independent Director
18.68K
--
Mr. Frank Mottola
Mr. Frank Mottola
Senior Vice President - Quality, GMP Operations and Information Technology and Regulatory Affairs
Senior Vice President - Quality, GMP Operations and Information Technology and Regulatory Affairs
15.15K
+4.64%
Dr. Padmanabh P. Bhatt, Ph.D.
Dr. Padmanabh P. Bhatt, Ph.D.
Senior Vice President - Intellectual Property, Chief Scientific Officer
Senior Vice President - Intellectual Property, Chief Scientific Officer
12.70K
+7.63%
Mr. Timothy C. (Tim) Dec, CPA
Mr. Timothy C. (Tim) Dec, CPA
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
12.68K
+7.65%
Dr. Jonathan Rubin, M.D.
Dr. Jonathan Rubin, M.D.
Senior Vice President, Chief Medical Officer - Research and Development
Senior Vice President, Chief Medical Officer - Research and Development
9.63K
+8.32%
Mr. Charles W. Newhall, III
Mr. Charles W. Newhall, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Bethany L. Sensenig
Ms. Bethany L. Sensenig
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Jack A. Khattar
Mr. Jack A. Khattar
President, Chief Executive Officer, Secretary, Director
President, Chief Executive Officer, Secretary, Director
2.01M
--
Mr. Frederick M. Hudson, CPA
Mr. Frederick M. Hudson, CPA
Independent Director
Independent Director
53.76K
--
Dr. Carrolee Barlow, M.D., Ph.D.
Dr. Carrolee Barlow, M.D., Ph.D.
Independent Director
Independent Director
22.57K
--
Dr. Georges Gemayel, Ph.D.
Dr. Georges Gemayel, Ph.D.
Independent Director
Independent Director
18.68K
--
Mr. Frank Mottola
Mr. Frank Mottola
Senior Vice President - Quality, GMP Operations and Information Technology and Regulatory Affairs
Senior Vice President - Quality, GMP Operations and Information Technology and Regulatory Affairs
15.15K
+4.64%
Dr. Padmanabh P. Bhatt, Ph.D.
Dr. Padmanabh P. Bhatt, Ph.D.
Senior Vice President - Intellectual Property, Chief Scientific Officer
Senior Vice President - Intellectual Property, Chief Scientific Officer
12.70K
+7.63%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Net product sales-Qelbree
64.75M
43.21%
Net product sales - GOCOVRI
30.69M
20.48%
Net product sales-APOKYN
14.98M
10.00%
Net product sales- Trokendi XR
12.80M
8.54%
Net product sales- Oxtellar XR
10.20M
6.81%
Other
16.41M
10.96%
地區USD
名稱
營收
佔比
United States
149.82M
100.00%
業務
地區
業務USD
名稱
營收
佔比
Net product sales-Qelbree
64.75M
43.21%
Net product sales - GOCOVRI
30.69M
20.48%
Net product sales-APOKYN
14.98M
10.00%
Net product sales- Trokendi XR
12.80M
8.54%
Net product sales- Oxtellar XR
10.20M
6.81%
Other
16.41M
10.96%
股東統計
更新時間: 5月8日 週四
更新時間: 5月8日 週四
持股股東
股東類型
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
14.65%
The Vanguard Group, Inc.
10.99%
Armistice Capital LLC
9.28%
Dimensional Fund Advisors, L.P.
5.19%
Macquarie Investment Management
4.82%
Other
55.07%
持股股東
持股股東
佔比
BlackRock Institutional Trust Company, N.A.
14.65%
The Vanguard Group, Inc.
10.99%
Armistice Capital LLC
9.28%
Dimensional Fund Advisors, L.P.
5.19%
Macquarie Investment Management
4.82%
Other
55.07%
股東類型
持股股東
佔比
Investment Advisor
56.83%
Investment Advisor/Hedge Fund
30.46%
Hedge Fund
15.36%
Individual Investor
4.11%
Research Firm
2.96%
Pension Fund
1.70%
Venture Capital
0.93%
Bank and Trust
0.70%
Sovereign Wealth Fund
0.27%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
563
63.74M
113.85%
-2.63M
2025Q1
587
64.77M
115.71%
-2.86M
2024Q4
569
65.17M
116.92%
-2.59M
2024Q3
551
65.02M
117.72%
-2.14M
2024Q2
536
63.49M
115.33%
-2.27M
2024Q1
535
61.47M
111.83%
-3.83M
2023Q4
534
61.60M
112.54%
-3.30M
2023Q3
534
60.88M
111.42%
-4.46M
2023Q2
534
61.11M
111.93%
-1.60M
2023Q1
539
59.34M
108.94%
-3.56M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
BlackRock Institutional Trust Company, N.A.
8.20M
14.65%
-297.23K
-3.50%
Mar 31, 2025
The Vanguard Group, Inc.
6.15M
10.99%
+13.13K
+0.21%
Mar 31, 2025
Armistice Capital LLC
5.20M
9.28%
+360.00K
+7.44%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
2.90M
5.19%
+25.18K
+0.87%
Mar 31, 2025
Macquarie Investment Management
2.70M
4.82%
+70.76K
+2.69%
Mar 31, 2025
State Street Global Advisors (US)
2.15M
3.83%
-42.85K
-1.96%
Mar 31, 2025
Khattar (Jack A)
2.01M
3.6%
--
--
Apr 22, 2025
Renaissance Technologies LLC
1.59M
2.83%
-13.00K
-0.81%
Mar 31, 2025
Stephens Investment Management Group, LLC
1.74M
3.1%
-13.59K
-0.78%
Mar 31, 2025
Loomis, Sayles & Company, L.P.
1.44M
2.57%
-26.38K
-1.80%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Neuroscience and Healthcare ETF
4.1%
Invesco Pharmaceuticals ETF
2.62%
SPDR S&P Pharmaceuticals ETF
2.05%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.45%
Invesco S&P SmallCap Health Care ETF
1.26%
Lattice Hartford Multifactor Small Cap ETF
0.93%
iShares U.S. Pharmaceuticals ETF
0.89%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.65%
VictoryShares Small Cap Free Cash Flow ETF
0.47%
Distillate Small/Mid Cash Flow ETF
0.47%
查看更多
iShares Neuroscience and Healthcare ETF
佔比4.1%
Invesco Pharmaceuticals ETF
佔比2.62%
SPDR S&P Pharmaceuticals ETF
佔比2.05%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
佔比1.45%
Invesco S&P SmallCap Health Care ETF
佔比1.26%
Lattice Hartford Multifactor Small Cap ETF
佔比0.93%
iShares U.S. Pharmaceuticals ETF
佔比0.89%
Pacer US Small Cap Cash Cows Growth Leaders ETF
佔比0.65%
VictoryShares Small Cap Free Cash Flow ETF
佔比0.47%
Distillate Small/Mid Cash Flow ETF
佔比0.47%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
